ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹7.45 Cr | ₹25 Cr | ₹20 Cr | ₹29 Cr | ₹33 Cr |
What is the latest Contingent Liabilities ratio of ANUH PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹7.45 Cr |
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹29 Cr |
| Mar2022 | ₹33 Cr |
How is Contingent Liabilities of ANUH PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.45 Cr | -70.49 | |
| Mar2025 | ₹25 Cr | 24.50 | |
| Mar2024 | ₹20 Cr | -30.61 | |
| Mar2023 | ₹29 Cr | -11.19 | |
| Mar2022 | ₹33 Cr | - | |
Compare Contingent Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹779.1 Cr | -1.8% | -1.5% | -17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -1.8% |
-1.5% |
-17.2% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses